Skip to main content
Premium Trial:

Request an Annual Quote

Codon, Duke, MIT Sue Blue Heron for Allegedly Infringing IP to Synthesize DNA

NEW YORK (GenomeWeb News) – Codon Devices, Duke University, and the Massachusetts Institute of Technology have sued Blue Heron Biotechnology for allegedly infringing five US patents that Codon has licensed exclusively from the universities.
 
The suit, filed in a US District Court in Delaware, claims that Blue Heron is infringing on four Duke patents used to map gene mutations, manipulate genes, and fractionate DNA molecules.
 
The claimants also say Blue Heron is infringing an MIT patent used to screen for genetic variation.
 
Condon disclosed the suit in a statement yesterday, but listed only itself as a plaintiff. Court documents obtained by GenomeWeb News show that Duke University and MIT are also plaintiffs in the case.
 
The plaintiffs claim that Blue Heron, by using its GeneMaker platform to hybridize and synthesize oligonucleotides and build genes from duplexes, is infringing these patents, some of them willfully.
 
In the complaint, Codon, Duke, and MIT seek damages and a permanent injunction that would bar Blue Heron from using the IP.
 
The patents, which cover DNA error correction technologies, include US Patent Nos. 5,459,039; 5,556,750; 5,679,522; 5,702,894; and 5,750,335, all of which are exclusively licensed to Codon Devices, Codon said in a statement.
 
Calls placed to Blue Heron were not immediately returned.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.